Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents-Reference-Cited by-同舟云学术

Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents

Published:2021-09-28 Issue:1 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Kahale Lara A¹,Matar Charbel F²,Tsolakian Ibrahim G³,Hakoum Maram B⁴,Yosuico Victor ED⁵,Terrenato Irene⁶,Sperati Francesca⁶,Barba Maddalena⁶,Hicks Lisa K⁷,Schünemann Holger⁸,Akl Elie A¹

Affiliation:

1. Faculty of Medicine; American University of Beirut; Beirut Lebanon

2. Department of Internal Medicine; University of Connecticut School of Medicine; Farmington Connecticut USA

3. Department of Obstertrics and Gynaecology; University of Toledo College of Medicine and Life Sciences; Ohio USA

4. Department of Family Medicine; Cornerstone Care Teaching Health Center; Mount Morris Pennsylvania USA

5. Buffalo Medical Group; Buffalo New York USA

6. Scientific Direction; IRCCS Regina Elena National Cancer Institute; Rome Italy

7. Medicine; St. Michael’s Hospital and the University of Toronto; Toronto Canada

8. Department of Health Research Methods, Evidence, and Impact; McMaster University; Hamilton Canada

Publisher

Wiley

Subject

Pharmacology (medical)

Reference60 articles.

1. Campos-Cabrera G Mendez-Garcia E Campos-Cabrera S Campos-Villagomez JL Campos-Cabrera V Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma Blood 5068

2. Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide;Larocca;Blood,2012

3. Phase Iii Study Of Enoxaparin Versus Aspirin Versus Low-Dose Warfarin As Thromboprophylaxis For Patients With Newly Diagnosed Multiple Myeloma Treated Upfront With Thalidomide-Containing Regimens;Cavo;Haematologica,2010

4. A phase III study of enoxaparin versus low-dose warfarin versus aspirin as thromboprophylaxis for patients with newly diagnosed multiple myeloma treated up-front with thalidomide-containing regimens.;Cavo;Blood,2008

5. A Phase III Study of Enoxaparin Versus Low-Dose Warfarin Versus Aspirin as Thromboprophylaxis for Patients with Newly Diagnosed Multiple Myeloma Treated up-Front with Thalidomide-Containing Regimens.;Cavo;Haematologica,2009

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of the IMPEDE VTE score for prediction of venous thromboembolism in Chinese patients with multiple myeloma: A single-center retrospective cohort study;Thrombosis Research;2024-04

2. Venous thromboembolism prophylaxis and multiple myeloma patients in real-life: Results of a large survey and clinical guidance recommendations from the IFM group;Thrombosis Research;2024-01

3. Novel cuproptosis-related lncRNAs can predict the prognosis of patients with multiple myeloma;Translational Cancer Research;2023-11

4. Thrombosis in multiple myeloma: mechanisms, risk assessment and management;Leukemia & Lymphoma;2023-08-16

5. Direct oral anticoagulants versus aspirin for primary thromboprophylaxis in patients with multiple myeloma undergoing outpatient therapy: A systematic review and updated meta‐analysis;British Journal of Haematology;2023-08-02